Awareness of prediabetes and diabetes among persons with clinical depression

Mary Rosedale, Shiela M. Strauss, Candice Knight, Dolores Malaspina

Research output: Contribution to journalArticle

Abstract

Background: Major depressive disorder (MDD) is highly comorbid with diabetes, a relationship underappreciated by clinicians. Purpose: Examine the proportion of nonpregnant individuals ≥20 years with MDD and elevated glucose and the demographic and clinical characteristics associated with unrecognized elevated glucose. Methods: 14,373 subjects who participated in the National Health and Nutrition Examination Survey (2007-2012) completed the PHQ-9 depression screen and had hemoglobin A1C (HbA1c) measured. PHQ-9 scores ≥10 and HbA1c scores ≥5.7% were defned as MDD and elevated HbA1c, respectively. Data were analyzed using complex survey sampling sofware. Results: 38.4% of the sample with MDD had elevated HbA1c readings. Compared with nondepressed subjects, they were significantly more likely to have elevated glucose readings (P = 0.003) and to be aware of their elevated glucose levels if they had a higher body mass index, family history of diabetes, more doctor visits in the past year, a usual care source, health insurance, or were taking hypertension or hypercholesterolemia medications. Conclusions: Many adults with MDD have elevated HbA1c levels, have never been advised of elevated HbA1c, have not received diabetes screening, and have minimal contact with a healthcare provider. Additional opportunities for diabetes risk screening in people with MDD are needed.

Original languageEnglish (US)
Article number839152
JournalInternational Journal of Endocrinology
Volume2015
DOIs
StatePublished - 2015

Fingerprint

Prediabetic State
Major Depressive Disorder
Hemoglobins
Depression
Glucose
Reading
Nutrition Surveys
Health Insurance
Hypercholesterolemia
Health Personnel
Body Mass Index
Demography
Hypertension

ASJC Scopus subject areas

  • Endocrine and Autonomic Systems
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Awareness of prediabetes and diabetes among persons with clinical depression. / Rosedale, Mary; Strauss, Shiela M.; Knight, Candice; Malaspina, Dolores.

In: International Journal of Endocrinology, Vol. 2015, 839152, 2015.

Research output: Contribution to journalArticle

@article{c6152cbbe0c241729a1df707b108ddb5,
title = "Awareness of prediabetes and diabetes among persons with clinical depression",
abstract = "Background: Major depressive disorder (MDD) is highly comorbid with diabetes, a relationship underappreciated by clinicians. Purpose: Examine the proportion of nonpregnant individuals ≥20 years with MDD and elevated glucose and the demographic and clinical characteristics associated with unrecognized elevated glucose. Methods: 14,373 subjects who participated in the National Health and Nutrition Examination Survey (2007-2012) completed the PHQ-9 depression screen and had hemoglobin A1C (HbA1c) measured. PHQ-9 scores ≥10 and HbA1c scores ≥5.7{\%} were defned as MDD and elevated HbA1c, respectively. Data were analyzed using complex survey sampling sofware. Results: 38.4{\%} of the sample with MDD had elevated HbA1c readings. Compared with nondepressed subjects, they were significantly more likely to have elevated glucose readings (P = 0.003) and to be aware of their elevated glucose levels if they had a higher body mass index, family history of diabetes, more doctor visits in the past year, a usual care source, health insurance, or were taking hypertension or hypercholesterolemia medications. Conclusions: Many adults with MDD have elevated HbA1c levels, have never been advised of elevated HbA1c, have not received diabetes screening, and have minimal contact with a healthcare provider. Additional opportunities for diabetes risk screening in people with MDD are needed.",
author = "Mary Rosedale and Strauss, {Shiela M.} and Candice Knight and Dolores Malaspina",
year = "2015",
doi = "10.1155/2015/839152",
language = "English (US)",
volume = "2015",
journal = "International Journal of Endocrinology",
issn = "1687-8337",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Awareness of prediabetes and diabetes among persons with clinical depression

AU - Rosedale, Mary

AU - Strauss, Shiela M.

AU - Knight, Candice

AU - Malaspina, Dolores

PY - 2015

Y1 - 2015

N2 - Background: Major depressive disorder (MDD) is highly comorbid with diabetes, a relationship underappreciated by clinicians. Purpose: Examine the proportion of nonpregnant individuals ≥20 years with MDD and elevated glucose and the demographic and clinical characteristics associated with unrecognized elevated glucose. Methods: 14,373 subjects who participated in the National Health and Nutrition Examination Survey (2007-2012) completed the PHQ-9 depression screen and had hemoglobin A1C (HbA1c) measured. PHQ-9 scores ≥10 and HbA1c scores ≥5.7% were defned as MDD and elevated HbA1c, respectively. Data were analyzed using complex survey sampling sofware. Results: 38.4% of the sample with MDD had elevated HbA1c readings. Compared with nondepressed subjects, they were significantly more likely to have elevated glucose readings (P = 0.003) and to be aware of their elevated glucose levels if they had a higher body mass index, family history of diabetes, more doctor visits in the past year, a usual care source, health insurance, or were taking hypertension or hypercholesterolemia medications. Conclusions: Many adults with MDD have elevated HbA1c levels, have never been advised of elevated HbA1c, have not received diabetes screening, and have minimal contact with a healthcare provider. Additional opportunities for diabetes risk screening in people with MDD are needed.

AB - Background: Major depressive disorder (MDD) is highly comorbid with diabetes, a relationship underappreciated by clinicians. Purpose: Examine the proportion of nonpregnant individuals ≥20 years with MDD and elevated glucose and the demographic and clinical characteristics associated with unrecognized elevated glucose. Methods: 14,373 subjects who participated in the National Health and Nutrition Examination Survey (2007-2012) completed the PHQ-9 depression screen and had hemoglobin A1C (HbA1c) measured. PHQ-9 scores ≥10 and HbA1c scores ≥5.7% were defned as MDD and elevated HbA1c, respectively. Data were analyzed using complex survey sampling sofware. Results: 38.4% of the sample with MDD had elevated HbA1c readings. Compared with nondepressed subjects, they were significantly more likely to have elevated glucose readings (P = 0.003) and to be aware of their elevated glucose levels if they had a higher body mass index, family history of diabetes, more doctor visits in the past year, a usual care source, health insurance, or were taking hypertension or hypercholesterolemia medications. Conclusions: Many adults with MDD have elevated HbA1c levels, have never been advised of elevated HbA1c, have not received diabetes screening, and have minimal contact with a healthcare provider. Additional opportunities for diabetes risk screening in people with MDD are needed.

UR - http://www.scopus.com/inward/record.url?scp=84929378572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929378572&partnerID=8YFLogxK

U2 - 10.1155/2015/839152

DO - 10.1155/2015/839152

M3 - Article

VL - 2015

JO - International Journal of Endocrinology

JF - International Journal of Endocrinology

SN - 1687-8337

M1 - 839152

ER -